The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice.

MLA

Yamazaki, Takanori, et al. “The Antifibrotic Agent Pirfenidone Inhibits Angiotensin II-Induced Cardiac Hypertrophy in Mice.” Hypertension Research : Official Journal of the Japanese Society of Hypertension, vol. 35, no. 1, Jan. 2012, pp. 34–40. EBSCOhost, https://doi.org/10.1038/hr.2011.139.

APA

Yamazaki, T., Yamashita, N., Izumi, Y., Nakamura, Y., Shiota, M., Hanatani, A., Shimada, K., Muro, T., Iwao, H., & Yoshiyama, M. (2012). The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice. Hypertension Research : Official Journal of the Japanese Society of Hypertension, 35(1), 34–40. https://doi.org/10.1038/hr.2011.139

Chicago

Yamazaki, Takanori, Naoto Yamashita, Yasukatsu Izumi, Yasuhiro Nakamura, Masayuki Shiota, Akihisa Hanatani, Kenei Shimada, Takashi Muro, Hiroshi Iwao, and Minoru Yoshiyama. 2012. “The Antifibrotic Agent Pirfenidone Inhibits Angiotensin II-Induced Cardiac Hypertrophy in Mice.” Hypertension Research : Official Journal of the Japanese Society of Hypertension 35 (1): 34–40. doi:10.1038/hr.2011.139.